Back
Supernus Pharmaceuticals, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
34
SUPN
Supernus Pharmaceuticals, Inc.
Last Price:
$45.07
Seasonality Move:
-0.27%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiSupernus Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Supernus Pharmaceuticals, Inc. has on average historically risen by 17.9% based on the past 13 years of stock performance.
-
Supernus Pharmaceuticals, Inc. has risen higher in 9 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 69.23%
-
Is Supernus Pharmaceuticals, Inc. Stock Undervalued?The current Supernus Pharmaceuticals, Inc. [SUPN] share price is $45.10. The Score for SUPN is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
SUPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Supernus Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Supernus Pharmaceuticals, Inc. has on average historically risen by 17.9% based on the past 13 years of stock performance.
Supernus Pharmaceuticals, Inc. Stock Rating
Sell
34
Supernus Pharmaceuticals, Inc. (SUPN)
is a Sell
Is Supernus Pharmaceuticals, Inc. overpriced?
-
Supernus Pharmaceuticals, Inc. has risen higher in 9 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 69.23%
Supernus Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
supernus.com
52-Week Data
52-Week High:
57.65
52-Week Low:
29.16
Prediction Charts
Market Cap:
2.6B
Price in USD:
45.10
Volume:
493.7K
Beta:
1.08
Technical Analysis
SMA50:
48.42
SMA100:
44.83
SMA200:
38.49
52-Wk Change:
21.4%
Stock Predictions
-
Is Supernus Pharmaceuticals, Inc. stock public?Yes, Supernus Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Supernus Pharmaceuticals, Inc. stock quote today?The Supernus Pharmaceuticals, Inc. stock price is 45.10 USD today.
-
How to buy Supernus Pharmaceuticals, Inc. stock online?You can buy Supernus Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 44.48 | 45.00 | 45.58 | 44.22 |
| Nov-17 | 45.30 | 45.09 | 45.96 | 44.70 |
| Nov-18 | 45.11 | 44.90 | 45.73 | 44.05 |
| Nov-19 | 44.69 | 45.70 | 46.00 | 44.52 |
| Nov-20 | 46.23 | 44.79 | 46.47 | 44.76 |
| Nov-21 | 44.73 | 45.32 | 46.09 | 44.37 |
| Nov-24 | 45.50 | 45.15 | 46.00 | 45.00 |
| Nov-25 | 45.62 | 46.08 | 46.79 | 45.16 |
| Nov-26 | 46.14 | 46.26 | 47.00 | 45.72 |
| Nov-28 | 46.39 | 45.59 | 46.57 | 45.53 |
| Dec-1 | 45.38 | 44.70 | 45.58 | 44.65 |
| Dec-2 | 44.70 | 44.12 | 44.90 | 44.09 |
| Dec-3 | 44.27 | 44.76 | 45.07 | 44.21 |
| Dec-4 | 44.76 | 45.10 | 45.10 | 44.28 |
Supernus Pharmaceuticals, Inc. Earnings
Supernus Pharmaceuticals, Inc. Earnings Report: Per Share Supernus Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Supernus Pharmaceuticals, Inc. Forecast Revenue Growth
Supernus Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.43 per share.
* Supernus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.